ICU — SeaStar Medical Holding Share News
0.000.00%
Last trade - 00:00- $13.48m
- $6.66m
- $1.23m
U.S. STOCKS ON THE MOVE-Morgan Stanley, Procter & Gamble, Lululemon
SeaStar jumps on FDA's 'breakthrough' tag for liver disease treatment device
Brief: FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation For Hepatorenal Syndrome
U.S. STOCKS ON THE MOVE-Hyatt Hotels, Walmart, Maxeon
U.S. STOCKS ON THE MOVE-Olema Pharma, Akamai Technologies, US banks
SeaStar, Nuwellis up on regulatory update for kidney injury treatment device
U.S. STOCKS ON THE MOVE-Mercato, Baytex, Ball Corp
U.S. STOCKS ON THE MOVE-SeaStar, Sigma Lithium, Brinker
SeaStar rises on FDA's 'breakthrough' tag for inflammation treatment device
SeaStar Medical Holding Corp reports results for the quarter ended in June - Earnings Summary
SeaStar Medical Holding Corp expected to post a loss of 25 cents a share - Earnings Preview
Brief: SeaStar Medical Holding Files Prospectus Relates To Offer, Resale From Time To Time Of Up To 1.1 Mln Shares Of Common Stock By Selling Stockholders
Brief: Seastar Medical Holding Corp Says On June 26, Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: SeaStar Medical Gets Notice Of Delisting Or Failure From Nasdaq
Brief: Seastar Medical Reports First Quarter 2023 Financial Results And Provides A Business Update
Brief: Seastar Medical Provides Regulatory Update Related To Its Hde Application For Pediatric Selective Cytopheretic Device
Brief: Seastar Medical Announces Activation Of First Clinical Site In Pivotal Trial With Selective Cytopheretic Device In Critically Ill Adults With Acute Kidney Injury
Brief: Seastar Medical Holding Corp Files Prospectus Relates To Offer, Resale, From Time To Time, Of Up To 14.2 Million Shares Of Common Stock By 3I, Lp
Brief: Seastar Medical Holding Corp Closes Initial $3.3 Million Tranche Of $9.8 Million Private Placement